ImmusanT, Inc.
5Patents
5Active
5Granted
41Portfolio score
Filing activity: Nov 30, 2009 → Nov 20, 2015 · 1 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8835603B2 | Agents for the treatment of celiac disease | Physics | 7 | Active |
| US9464120B2 | Compositions for treatment of celiac disease | Physics | 3 | Active |
| US10473647B1 | Peptides for use in treatment and diagnosis of type 1 diabetes | Physics | 2 | Active |
| US10449228B2 | Dosage of a gluten peptide composition | Physics | 0 | Active |
| US10370718B2 | Use of HLA genetic status to assess or select treatment of celiac disease | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.